Results 291 to 300 of about 113,866 (372)
The release of adrenaline and noradrenaline from the adrenal glands of the foetal sheep
, 1961 R. S. Comline, M. Silver
openalex +2 more sources
Angiosarcoma of the adrenal gland
Polish Archives of Internal Medicine, 2013 Michał Holecki +3 more
openaire +3 more sources
Brain Pathology, EarlyView.Target‐enriched enzymatic methylation sequencing (TEEM‐seq), a DNA methylation sequencing method using the Twist Human Methylome panel, shows comparable performance to array‐based tumor methylation profiling. The method is compatible with both frozen and formalin‐fixed paraffin‐embedded (FFPE) samples and is a viable approach to tumor methylation and ...
Quynh T. Tran +6 more
wiley +1 more source
Greetings from below the aortic arch! The paradigm of cardiac paraganglioma. [PDF]
, 1996 Heufelder, Armin E., Hofbauer, Lorenz C.
core +1 more source
The percentage of noradrenaline in the adrenal glands of litter‐mate cats
, 1962 K.R. Butterworth, Monica Mann
openalex +2 more sources
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Cancer Science, EarlyView.In advanced EGFR‐mutant NSCLC, high PD‐L1 expression may indicate reduced efficacy of third‐generation EGFR‐TKIs. PD‐L1 expression in primary lesions may serve as a prognostic marker, whereas expression in metastatic lymph nodes does not. This spatial heterogeneity could affect PD‐L1's predictive accuracy for third‐generation EGFR‐TKIs efficacy ...
Yidan Zhang +7 more
wiley +1 more source